UroGen Pharma Ltd. Ordinary Shares Earnings Dividend
Earnings Summary
Revenue | $72.46Mn |
Net Profits | $-14.35Mn |
Net Profit Margins | -19.81% |
UroGen Pharma Ltd. Ordinary Shares’s revenue jumped 199.22% since last year same period to $72.46Mn in the Q2 2026. On a quarterly growth basis, UroGen Pharma Ltd. Ordinary Shares has generated 42.18% jump in its revenue since last 3-months.
UroGen Pharma Ltd. Ordinary Shares’s net profit jumped 71.26% since last year same period to $-14.35Mn in the Q2 2026. On a quarterly growth basis, UroGen Pharma Ltd. Ordinary Shares has generated 39.12% jump in its net profits since last 3-months.
UroGen Pharma Ltd. Ordinary Shares’s net profit margin jumped 90.4% since last year same period to -19.81% in the Q2 2026. On a quarterly growth basis, UroGen Pharma Ltd. Ordinary Shares has generated 57.19% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.38 |
EPS Estimate Current Year | 0.38 |
UroGen Pharma Ltd. Ordinary Shares’s earning per share (EPS) estimates for the current quarter stand at 0.38 - a 200% jump from last quarter’s estimates.
UroGen Pharma Ltd. Ordinary Shares’s earning per share (EPS) estimates for the current year stand at 0.38.
Key Ratios
Earning Per Share (EPS) | -0.28 |
UroGen Pharma Ltd. Ordinary Shares’s earning per share (EPS) jumped 73.33% since last year same period to -0.28 in the Q2 2026. This indicates that the UroGen Pharma Ltd. Ordinary Shares has generated 73.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-06 | -0.48 | -0.47 | 2.08% |
2026-08-05 | -0.38 | -0.28 | 26.32% |
